Earlier this month, Waters Corporation launched the Xevo Charge Detection Mass Spectrometer (CDMS), offering direct, individual-particle mass measurement of mega-mass biomolecules critical to ...

More than 40 years after the first AIDS cases, new long-acting drugs and antibody-based therapies are reviving hopes that HIV ...

Rapid advances in viral vectors, advanced plasmid DNA and oncology drive new expansion in global markets.Austin, Oct. 17, 2025 (GLOBE NEWSWIRE) -- Gene Therapy Starting Materials Market Size & Growth ...

Waters Corporation (NYSE: WAT) today unveiled the Waters Xevo Charge Detection Mass Spectrometer (CDMS), delivering unmatched ...

After axing a wide swath of federal research projects and grants, a recent slew of awards offers a glimpse into the kinds of ...

VectorBuilder, a global leader in gene delivery technologies and CDMO services, today announced the publication of the miniVec plasmid system, engineered for safer, more efficient, and more scalable ...

Waters unveils charge detection MS technology to spur development of next-generation biotherapeutics: Our Bureau, Bengaluru Wednesday, October 15, 2025, 11:45 Hrs [IST] Waters unv ...

The Xevo CDMS enhances analysis of large biomolecules, crucial for next-gen therapeutics, using individual-particle mass measurement for molecules up to 150+ MDa. Electrostatic Linear Ion Trap (ELIT) ...

Novel platform uses DNA-loaded polymeric nanoparticles to precisely reprogram cells in patients, offering potential to reset the immune system and ...

The global swine industry faces a persistent and evolving challenge from viral pathogens, foremost among them being Porcine ...

Russia's Sputnik V vaccine is 92% effective at protecting people from COVID-19 according to interim trial results, the country's sovereign wealth fund said on Wednesday, as Moscow rushes to keep pace ...